###begin article-title 0
###xml 34 40 <span type="species:ncbi:10090">Murine</span>
Lipid Alterations in Experimental Murine Colitis: Role of Ceramide and Imipramine for Matrix Metalloproteinase-1 Expression
###end article-title 0
###begin p 1
Conceived and designed the experiments: JB JB. Performed the experiments: JB GL CH CH. Analyzed the data: JB JB. Contributed reagents/materials/analysis tools: GL GS FO. Wrote the paper: JB JB.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Dietary lipids or pharmacologic modulation of lipid metabolism are potential therapeutic strategies in inflammatory bowel disease (IBD). Therefore, we analysed alterations of bioactive lipids in experimental models of colitis and examined the functional consequence of the second messenger ceramide in inflammatory pathways leading to tissue destruction.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 138 144 <span type="species:ncbi:10090">murine</span>
###xml 279 284 <span type="species:ncbi:9606">human</span>
###xml 313 321 <span type="species:ncbi:9606">patients</span>
###xml 873 878 <span type="species:ncbi:9606">human</span>
Chronic colitis was induced by dextran-sulphate-sodium (DSS) or transfer of CD4+CD62L+ cells into RAG1-/--mice. Lipid content of isolated murine intestinal epithelial cells (IEC) was analysed by tandem mass spectrometry. Concentrations of MMP-1 in supernatants of Caco-2-IEC and human intestinal fibroblasts from patients with ulcerative colitis were determined by ELISA. Imipramine was used for pharmacologic inhibition of acid sphingomyelinase (ASM). Ceramide increased by 71% in chronic DSS-induced colitis and by 159% in the transfer model of colitis. Lysophosphatidylcholine (LPC) decreased by 22% in both models. No changes were detected for phosphatidylcholine. Generation of ceramide by exogenous SMase increased MMP-1-protein production of Caco-2-IEC up to 7-fold. Inhibition of ASM completely abolished the induction of MMP-1 by TNF or IL-1beta in Caco-2-IEC and human intestinal fibroblasts.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Mucosal inflammation leads to accumulation of ceramide and decrease of LPC in the intestinal epithelium. One aspect of ceramide generation is an increase of MMP-1. Induction of MMP-1 by TNF or IL-1beta is completely blocked by inhibition of ASM with imipramine. Therefore, inhibition of ASM may offer a treatment strategy to reduce MMP-1 expression and tissue destruction in inflammatory conditions.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 317 320 314 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Schtze1">[1]</xref>
###xml 321 324 318 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Wymann1">[4]</xref>
###xml 400 403 397 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Fabia1">[5]</xref>
###xml 404 407 401 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Stremmel1">[7]</xref>
###xml 449 452 446 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Sakata1">[8]</xref>
Many signalling molecules involved in the pathogenesis of inflammatory bowel disease (IBD) such as tumor necrosis factor (TNF) or interleukin-1 beta (IL-1beta) cause alterations of the lipid composition in the cell membrane by activation of various phospholipases, sphingomyelinases and other lipid modifying enzymes [1]-[4]. Previous reports demonstrated therapeutic effects of lipid administration [5]-[7] or inhibition of lipid modifying enzymes [8] for the treatment of intestinal inflammation. Ceramide or lysophosphatidylcholine play key roles as second messengers for intracellular signalling with the potential to control inflammatory responses.
###end p 9
###begin p 10
###xml 415 418 415 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Smith1">[9]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Gulbins1">[10]</xref>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Ballou1">[11]</xref>
###xml 567 571 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Kolesnick1">[12]</xref>
###xml 662 665 662 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Smith1">[9]</xref>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Gulbins2">[13]</xref>
###xml 944 948 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Gulbins2">[13]</xref>
###xml 950 954 950 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Duan1">[14]</xref>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Sakata2">[15]</xref>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
Ceramide is generated by de novo synthesis or hydrolysis of plasma membrane sphingomyelin via the action of sphingomyelinases (SMases). SMases are characterized by their optimal pH and are divided accordingly into acid, neutral and basic sphingomyelinase species. The acid sphingomyelinase (ASM) contributes to lysosomal sphingomyelin turnover and is also secreted upon cellular treatment with inflammatory stimuli [9], [10]. Ceramide has been implicated in a variety of cellular processes from cell growth, differentiation and gene transcription to cell death [11], [12]. Ceramide seems to play a central role for the pathophysiology of several common diseases [9] and is a key mediator for apoptosis, cellular invasion of bacteria and viruses, radiation- and chemotherapeutic responses, heat damage, UVA-light and ischemia-reperfusion injury [13]. Increasing evidence suggests implications of SMases in the development of colon cancer or IBD [13], [14]. Inhibition of ASM has been shown to protect from DSS-induced colitis in mice [15]. The authors suggested that the protective effect of ASM-inhibition was mediated by the suppression of cytokine production from macrophages in response to LPS. Unfortunately, the response of intestinal epithelial cells (IEC) and fibroblasts has not been investigated, although these cells may well contribute to the protective effects of ASM-inhibition.
###end p 10
###begin p 11
###xml 191 194 191 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Fabia1">[5]</xref>
###xml 362 365 362 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Mourelle1">[6]</xref>
###xml 513 516 513 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Stremmel1">[7]</xref>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Ehehalt1">[16]</xref>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Treede1">[17]</xref>
###xml 910 911 910 911 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 941 945 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-McKean1">[18]</xref>
###xml 1079 1083 1079 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Olofsson1">[19]</xref>
###xml 1233 1237 1233 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Maskrey1">[20]</xref>
###xml 187 190 <span type="species:ncbi:10116">rat</span>
###xml 229 232 <span type="species:ncbi:10116">rat</span>
Phosphatidylcholine (PC) is the main phospholipid component of eukaryotic cells. Instillation of PC and phosphatidylinositol have been shown to prevent acetic acid-induced colitis in the rat [5]. The formation of strictures in a rat model of colitis was also prevented by oral supplementation of polyunsaturated PC, possibly by stimulation of collagen breakdown [6]. The studies by Stremmel et al focused on the content of PC in mucus layers as the possible culprit for uncontrolled inflammation of the intestine [7], [16] which may be prevented by administration of PC. Nevertheless, in vitro studies revealed that exogenously added PC is also integrated into the cells and has anti-inflammatory properties in Caco-2 intestinal epithelial cells, especially in response to TNF [17]. Lysophosphatidylcholine (LPC) is a metabolic product of PC and displays inflammatory activity. Biosynthesis is regulated by PLA2 that catalyzes PC hydrolysis [18]. LPC acts as a chemotactic factor for monocytes and T cells and displays proinflammatory properties even at nanomolar concentrations [19]. Phosphatidylethanolamine (PE) and plasmalogenes (PE-pl) serve as precursors for lipoxygenases, thereby contributing to immune-regulatory activities [20].
###end p 11
###begin p 12
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Wang1">[21]</xref>
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Meijer1">[22]</xref>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Westermarck1">[23]</xref>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Sengupta1">[24]</xref>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Naito1">[25]</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-WojtowiczPraga1">[26]</xref>
###xml 813 817 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Naito1">[25]</xref>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Baugh1">[27]</xref>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Heuschkel1">[28]</xref>
###xml 919 923 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Mackay1">[29]</xref>
###xml 944 948 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Lafuma1">[30]</xref>
###xml 968 972 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Wlaschek1">[31]</xref>
###xml 1129 1133 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Reunanen1">[32]</xref>
###xml 1135 1139 1132 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Bu1">[33]</xref>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Excessively produced Matrix Metalloproteinase-1 (MMP-1) is believed to damage the colonic mucosa in patients with ulcerative colitis [21], [22]. MMP-1, also called interstitial collagenase, belongs to a family of zinc-dependent metalloendopeptidases collectively capable of degrading essentially all extracellular matrix (ECM) components [23], [24]. Most of the MMPs are secreted as proenzymes and require proteolytic cleavage for activation [25]. Activity of MMPs is further regulated by a group of endogenous proteins, so called tissue inhibitors of metalloproteinases (TIMPs) that bind to active and alternative sites of activated MMPs [26]. The balance of activated MMPs and TIMPs is crucial to maintain tissue allostasis. Excessive production or activation of MMPs results in uncontrolled degradation of ECM [25], [27], [28]. MMP-1 is increased upon stimulation with inflammatory cytokines such as IL-1beta or TNF [29], ionizing radiation [30] or UVA irradiation [31]. Expression of MMP-1 has been linked with ceramide metabolism via activation of extracellular signal-regulated and stress-activated protein kinase pathways [32], [33] but the relevance of this association for the mentioned stimuli and the involvement of endogenous SMases remain to be determined. ASM-activating cytokines and stimuli greatly overlap with the stimulatory processes which increase MMP-1. Therefore, we investigated the effects of these stimuli on MMP-1 production in IEC and intestinal fibroblasts.
###end p 12
###begin p 13
###xml 111 117 <span type="species:ncbi:10090">murine</span>
To determine the occurring lipid alterations in intestinal inflammation, we quantified bioactive lipids in two murine models of chronic colitis. The increase of ceramide was linked with the secretion of MMP-1. Exogenous SMase produced high levels of MMP-1 in Caco-2 IEC and induction of MMP-1 by TNF or IL-1beta was completely abrogated by inhibition of ASM with imipramine.
###end p 13
###begin title 14
Materials and Methods
###end title 14
###begin title 15
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 15
###begin p 16
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
Female Balb/c (Harlan Winkelmann, Borchen, Germany) and RAG1-/- mice (Taconic, USA) weighing 19-22 g were individually housed in standard polycarbonate mouse cages for at least two weeks before the start of the experiment. All mice were kept under standard laboratory conditions (12-h light/dark cycle, 22+/-2degreesC; 60+/-5% humidity). All experimental protocols were approved by the Committee on Animal Health and Care of the local government (AZ 621-2531.1-08/04), and conformed to international guidelines on the ethical use of animals. All efforts were made to minimize the number of animals used and their suffering.
###end p 16
###begin title 17
Cells and reagents
###end title 17
###begin p 18
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 104 108 <span type="species:ncbi:9913">calf</span>
###xml 598 619 <span type="species:ncbi:1280">staphylococcus aureus</span>
Caco-2 cells were maintained in Dulbecco's minimum essential medium (DMEM), supplemented with 10% fetal calf serum (FCS), 1% penicillin/streptomycin, 1% non-essential amino acids and 1% sodium pyruvate in an atmosphere containing 10% CO2 at 37degreesC. FCS was inactivated for 1h, 50degreesC. Isolation and cultivation of fibroblasts is described below. For quantification of MMP-1 protein by ELISA, experiments were performed without FCS. To avoid prestimulation by serum withdrawal, primary fibroblasts were maintained in medium with 0.5% FCS prior to stimulation with TNF. Sphingomyelinase from staphylococcus aureus and imipramine were purchased from Sigma-Aldrich, Taufkirchen, Germany. IL-1beta, TNF and MMP-1 ELISA were purchased from R&D Systems, Wiesbaden, Germany.
###end p 18
###begin title 19
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Isolation of human fibroblasts from patients
###end title 19
###begin p 20
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Leeb1">[34]</xref>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Brenmoehl1">[35]</xref>
###xml 372 374 372 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 381 383 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 828 829 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
Human fibroblasts were isolated from colonic sections of patients with ulcerative colitis or sections of non-IBD patients without inflammation. Fibroblasts were isolated and cultured as previously described [34], [35]. In brief, the mucosa from surgical patients was cut into 1-mm pieces and epithelial cells were removed in Hank's Balanced Salt Solution (HBSS) without Ca2+ and Mg2+ (PAA, Colbe, Germany) with 2mM ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich, Taufkirchen, Germany). The remaining tissue was digested for 30 min at 37degreesC in phosphate-buffered saline (PBS, Gibco, Karlsruhe, Germany) containing 1 mg/ml collagenase I (Sigma-Aldrich), 0.3mg/ml DNase I (Roche, Mannheim, Germany), and 2mg/ml hyaluronidase (Sigma-Aldrich). Isolated cells were washed with DMEM containing 20% FCS and cultured in 25-cm2 culture flasks (Costar, Bodenheim, Germany) with DMEM containing 10% FCS, penicillin (100IU/ml), streptomycin (100 microg/ml), ciprofloxacin (8 microg/ml), gentamycin (50 microg/ml), and amphotericin B (1 microg/ml). Non-adherent cells were removed by subsequent changes of medium.
###end p 20
###begin title 21
Antibodies
###end title 21
###begin p 22
###xml 71 74 <span type="species:ncbi:10116">Rat</span>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 212 216 <span type="species:ncbi:9925">goat</span>
###xml 222 225 <span type="species:ncbi:10116">rat</span>
The following antibodies were used for flow cytometry (FACS) analysis: Rat anti-mouse G8.8 (Ep-CAM) antibody was a kind gift by Dr. U. Strauch, Regensburg, Germany. Fluorescein (FITC) conjugated F(ab')2 fragment goat anti-rat IgG were from Jackson ImmunoResearch, Suffolk, UK.
###end p 22
###begin title 23
MMP-1 ELISA
###end title 23
###begin p 24
For detection of MMP-1, fibroblasts and Caco-2 cells were seeded in 12-well plates. Experiments were performed in medium without FCS or 0.5% FCS in the case of stimulation by TNF. Cells were incubated with the indicated substances. For pharmacologic inhibition of ASM imipramine (30 microM) was used. Concentration of MMP-1 in supernatants was determined by ELISA (R&D Systems). All measurements were performed in duplicate.
###end p 24
###begin title 25
Dextran sulphate sodium (DSS) induced chronic colitis
###end title 25
###begin p 26
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Obermeier1">[36]</xref>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">Mice</span>
For induction of chronic colitis mice received 3% DSS (MP Biomedicals, Illkirch, France) in drinking water for 7 days, as described previously [36]. Each cycle consisted of 3% DSS in drinking water for 7 days, followed by a 7 days interval with normal drinking water. Mice were failed to 4 cycles and were used for the experimental treatment 4 weeks after completion of the last cycle.
###end p 26
###begin title 27
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CD4+CD62L+ T cell transfer model of colitis
###end title 27
###begin p 28
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Neurath1">[37]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Mudter1">[38]</xref>
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 189 190 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 195 196 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 324 325 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 449 452 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
Splenic CD4+CD62L+ T cells from Balb/c mice were isolated as described previously [37], [38]. In brief, CD4+CD62L+ T cells were purified from spleen mononuclear cells of healthy mice by CD4+CD62L+ T Cell isolation kit with immunomagnetic microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany). CD4+CD62L+ T cells (0.25x106) were resuspended in 200 microl of sterile phosphate buffered saline (PBS) and injected intraperitoneally in recipient RAG1-/- deficient mice. Colitis activity was monitored by weight changes and histological analysis. After 6-8 weeks mice were used for experiments.
###end p 28
###begin title 29
Histological score
###end title 29
###begin p 30
###xml 226 230 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Obermeier1">[36]</xref>
###xml 232 236 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Steidler1">[39]</xref>
For the histological analyses cross sections of the colon were fixed in 4% formalin and the tissue was embedded in paraffin, sliced in sections of 2 microm thickness and stained with haematoxylin-eosin and scored as described [36], [39]. The predominant feature of microscopic inflammation in colitis is the mononuclear cell infiltration limited to the mucosa and the consecutive mucosal damage with loss of goblet cells and loss of crypts. Both features were independently graded from 0 to 4 and the mean score was noted. The total histological score represents the sum of the epithelium and infiltration score and ranges from 0 to 8.
###end p 30
###begin title 31
Affymetrix gene array
###end title 31
###begin p 32
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Langmann1">[40]</xref>
###xml 725 727 721 723 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sub>
###xml 891 907 887 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 2002 2006 1982 1986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Langmann1">[40]</xref>
###xml 359 364 <span type="species:ncbi:9606">human</span>
###xml 400 405 <span type="species:ncbi:9606">human</span>
###xml 891 907 <span type="species:ncbi:562">Escherichia coli</span>
First, Caco-2 cells (6x75cm2 flask) were stimulated with exogenous SMase (0.1 U/ml) for 6h and 24h. After incubation, cells were isolated with RNeasy Mini Kit (Qiagen, Hilden, Germany). Gene expression profiles were determined as described before [40] using Affymetrix HGU133A and HGU133B GeneChips (Affymetrix, Santa Clara, CA), which cover 22,283 annotated human genes (U133A) and more than 33,000 human EST sequences (U133B). Caco-2 RNA stimulated with exogenous SMase (6h and 24h) was used for pooling to generate complementary RNA (cRNA). The remaining amount of RNA was used for real-time RT-PCR validation in single samples. 10 microg of pooled total RNA was converted to complementary DNA (cDNA) using a T7-oligo-d(T)24 primer and SuperScript reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Second-strand cDNA synthesis and blunt ending was performed using T4 DNA polymerase, Escherichia coli DNA ligase, and T4 polynucleotide kinase. Following phenol-chloroform extraction, cDNA was used for in vitro transcription reaction using the T7 BioArray High Yield RNA Transcript Labeling Kit (Enzo Diagnostics, Farmingdale, NY, USA) to produce biotinylated cRNA. Thereafter, the labeled cRNA was purified using RNeasy Mini Kit columns (Qiagen) and fragmented by incubation at 94degreesC for 30 minutes. Fragmentation was checked by microcapillary electrophoresis on an Agilent 2100 bioanalyzer, and 30 microg of biotinylated cRNAs was split into 2 parts and hybridized to U133A and U133B GeneChips, respectively, for 16 hours at 45degreesC with constant rotation. Microarray was processed in an Affymetrix GeneChip Fluidics Station 400. Following staining with streptavidin-conjugated phycoerythrin and washing cycles, the microarrays were scanned using the GeneArray Scanner (Agilent Technologies). Expression signals for each transcript and comparisons between different samples were calculated with the Affymetrix GeneChip software MAS5.0 and Microsoft Excel (Microsoft Corp., Redmond, WA) [40].
###end p 32
###begin title 33
Tandem mass spectrometry
###end title 33
###begin p 34
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Daig1">[41]</xref>
###xml 211 212 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 265 266 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 401 405 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Liebisch1">[42]</xref>
###xml 407 411 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Wiesener1">[43]</xref>
###xml 560 564 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Liebisch1">[42]</xref>
###xml 587 590 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 740 743 732 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 752 755 744 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 901 904 893 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Intestinal epithelial cells (IECs) were isolated from mice colon as previous described [41]. After isolation, cells were washed with ice-cold PBS twice. Samples were prepared by addition of 500 microl ice-cold H2O with 0.2% SDS, followed by addition of 500 microl H2O. Lipids were quantified by electrospray ionization tandem mass spectrometry (ESI-MS/MS) in positive ion mode as described previously [42], [43]. Samples were quantified by direct flow injection analysis using the analytical setup and the data analysis algorithms described by Liebisch et al. [42]. A parent ion scan of m/z 184 specific for phosphocholine containing lipids was used for phosphatidylcholine, sphingomyelin and lysophosphatidylcholine. Neutral loss scans of m/z 141 and m/z 185 were used for phosphatidylethanolamine and phosphatidylserine, respectively. PE-based plasmalogens (PE-pl) were analysed by fragment ions of m/z 364, 380 and 382 for PE p16:0, p18:1 and p18:0 species, respectively. Ceramide was analysed using N-heptadecanoyl-sphingosine as internal standard. Free cholesterol (FC) and CE species were determined after selective acetylation of FC. Quantification was achieved by calibration lines generated by addition of naturally occurring lipid species to cell homogenates.
###end p 34
###begin title 35
Statistical analysis
###end title 35
###begin p 36
Data are shown using vertical Box-Whisker plots (25% and 75% values), generated in the basic module of the programs SigmaPlot/SigmaStat. Statistical analysis was performed by student's t-test or Mann-Whitney U-test, with p<0.05 considered statistically significant. Data are given as means +/- SEM.
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Lipid alterations in chronic DSS-induced colitis and CD4+CD62L+ transfer model of colitis: increase of ceramide, decrease of lysophosphatidylcholine
###end title 38
###begin p 39
To identify inflammation induced lipid alterations, we first analysed the occurring changes of bioactive lipids in experimental models of chronic colitis by tandem mass spectrometry.
###end p 39
###begin p 40
###xml 137 149 137 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g001">Figure 1A&#8211;1C</xref>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Isolated colonic IEC of mice suffering from chronic DSS-induced colitis showed the following lipid alterations when compared to control (Figure 1A-1C):
###end p 40
###begin title 41
Increase of ceramide and decrease of LPC in chronic DSS-induced colitis.
###end title 41
###begin p 42
(A-C) Lipid analysis of isolated colonic IEC by tandem mass spectrometry (control n = 12, 3% DSS n = 10). (A) Proportion of ceramide and LPC of analysed lipids. (B) Proportion of PC and FC of analysed lipids. (C) Proportion of SM, PE and PE-pl of analysed lipids. (D) Histological score. (E) Surface expression of epithelial cell marker, determined by flow cytometry after staining of the cells with FITC-labelled anti G8.8 antibodies. (**p<0.01, ***p<0.001)
###end p 42
###begin p 43
###xml 27 36 27 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g001">Figure 1A</xref>
###xml 100 109 100 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g001">Figure 1A</xref>
###xml 161 170 161 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g001">Figure 1B</xref>
###xml 191 200 191 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g001">Figure 1B</xref>
###xml 218 227 218 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g001">Figure 1C</xref>
###xml 260 269 260 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g001">Figure 1C</xref>
###xml 296 305 296 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g001">Figure 1C</xref>
###xml 397 406 397 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g001">Figure 1D</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Farr1">[44]</xref>
###xml 648 657 648 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g001">Figure 1E</xref>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
Ceramide increased by 71% (Figure 1A). In contrast, lysophosphatidylcholine (LPC) decreased by 22% (Figure 1A). Levels of phosphatidylcholine remained constant (Figure 1B). Free cholesterol (Figure 1B), Sphingomyelin (Figure 1C) and phosphatidyl-ethanolamine (Figure 1C) declined. Plasmalogenes (Figure 1C) increased. Histological score of mice with DSS-induced colitis versus control is shown in Figure 1D. To exclude contamination of IEC by other cells, isolated cells were stained with FITC-coupled anti-G8.8 antibodies, specific for epithelial cells [44]. Flow cytometry revealed that more than 93% of isolated cells were of epithelial origin (Figure 1E), indicating a good purification of IEC without relevant numbers of other mucosal cells.
###end p 43
###begin p 44
###xml 61 62 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 108 124 108 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g002">Figure 2A and 2B</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
Colonic IEC from mice with chronic colitis by transfer of CD4+CD62L+ cells displayed the following changes (Figure 2A and 2B):
###end p 44
###begin title 45
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 100 103 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Increase of ceramide and decrease of LPC in chronic colitis by transfer of CD4+CD62L+ cells in RAG-1-/- mice.
###end title 45
###begin p 46
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(A,B) Lipid analysis of isolated colonic IEC by tandem mass spectrometry (control n = 3, CD4+CD62L+ n = 6). (A) Proportion of ceramide and LPC of analysed lipids. (B) Proportion of PC and FC of analysed lipids. (C) Histological score. (*p<0.05)
###end p 46
###begin p 47
###xml 28 37 28 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g002">Figure 2A</xref>
###xml 101 110 101 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g002">Figure 2A</xref>
###xml 144 153 144 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g002">Figure 2B</xref>
###xml 177 186 177 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g002">Figure 2B</xref>
###xml 240 241 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 246 247 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 311 320 311 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g002">Figure 2C</xref>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
Ceramide increased by 159% (Figure 2A). In contrast, lysophosphatidylcholine (LPC) decreased by 22% (Figure 2A). Levels of phosphatidylcholine (Figure 2B) and free cholesterol (Figure 2B) remained constant. Histological score of mice in CD4+CD62L+ transfer model of colitis was higher compared to control mice (Figure 2C).
###end p 47
###begin title 48
Increased expression of MMP-1- and MMP-10-mRNA by exogenous SMase in Caco-2 intestinal epithelial cells (IEC)
###end title 48
###begin p 49
###xml 387 395 387 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g003">Figure 3</xref>
Based on the differences found in chronic colitis, we examined the effects of ceramide generation in IEC by affymetrix gene array analysis. Therefore the colorectal cancer cell line Caco-2 was incubated with exogenous SMase (0.1 U/ml) to identify ceramide induced effects possibly involved in IBD pathophysiology. The experiments revealed a fast and robust increase of MMP-1 and MMP-10 (Figure 3). The induction of MMP-10 was not further investigated.
###end p 49
###begin title 50
Induction of MMP-1- and MMP-10-mRNA in the intestinal epithelial cell line Caco-2 after generation of ceramide by exogenous SMase (0,1U/ml), as determined by affymetrix gene array analysis.
###end title 50
###begin p 51
Data are presented as relative increase after 6h and 24h in comparison to untreated control. (n = 4; ***p<0.001)
###end p 51
###begin title 52
Exogenous Sphingomyelinase increases MMP-1 protein production in Caco-2 cells
###end title 52
###begin p 53
###xml 197 205 197 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g004">Figure 4</xref>
###xml 385 393 385 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g004">Figure 4</xref>
MMP-1 protein production upon generation of ceramide was confirmed by quantification of active MMP-1 by ELISA. Supernatants of Caco-2 cells were analysed 24h after incubation with exogenous SMase (Figure 4). Exogenous SMase led to a dose-dependent increase of MMP-1 with a 3.1-fold increase at concentrations as low as 0.005 U/ml and maximal increase at a concentration of 0.125 U/ml (Figure 4).
###end p 53
###begin title 54
MMP-1 protein expression of Caco-2 IEC is induced by exogenous SMase.
###end title 54
###begin p 55
Cells were incubated with increasing doses of exogenous SMase. Concentration of active MMP-1 was determined in supernatants after 24h by ELISA. (*p<0.05, **p<0.01; n = 6)
###end p 55
###begin title 56
Inhibition of acid sphingomyelinase (ASM) by imipramine completely abrogates the induction of MMP-1 by IL-1betaand TNF
###end title 56
###begin p 57
###xml 292 296 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Albouz1">[45]</xref>
###xml 297 301 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Jensen1">[47]</xref>
###xml 430 439 418 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g005">Figure 5A</xref>
###xml 503 512 491 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g005">Figure 5A</xref>
###xml 580 589 566 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g005">Figure 5A</xref>
###xml 670 679 656 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g005">Figure 5A</xref>
MMP-1 production in Caco-2 cells was induced by stimulation of cells with the ASM-activating inflammatory cytokines TNF (10ng/ml) or IL-1beta (1ng/ml). For inhibition of acid sphingomyelinase, cells were incubated with imipramine (30 microM). Imipramine causes proteolytic degradation of ASM [45]-[47] and was therefore added to the cells 30 minutes prior to stimulation. IL-1beta induced a 2.9-fold (+/-0.07) secretion of MMP-1 (Figure 5A) which was completely absent in cells treated with imipramine (Figure 5A). MMP-1 increased by 2.5-fold (+/-0.1) after stimulation with TNF (Figure 5A) while treatment of the cells with imipramine completely blocked this increase (Figure 5A). These results demonstrate ASM-dependence of IL-1beta and TNF for MMP-1 induction in the colon epithelial cell line.
###end p 57
###begin title 58
Pharmacological inhibition of ASM by imipramine abrogates induction of MMP-1 by IL-1beta and TNF.
###end title 58
###begin p 59
###xml 326 334 <span type="species:ncbi:9606">patients</span>
Concentration of MMP-1 in supernatants was determined after 24h by ELISA. (A) Stimulation of Caco-2 IEC with IL-1beta or TNF +/- imipramine (n = 5). (B) Stimulation of primary control fibroblasts CO I (n = 12), CO II (n = 9) and CO III (n = 10) with IL-1beta or TNF +/- imipramine. (C) Stimulation of primary fibroblasts from patients with ulcerative colitis UC I (n = 10), UC II (n = 6) and UC III (n = 6) with IL-1beta or TNF +/- imipramine. (*p<0.05, **p<0.01; ***p<0.001)
###end p 59
###begin p 60
###xml 625 641 619 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g005">Figure 5B and 5C</xref>
###xml 749 758 740 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g005">Figure 5B</xref>
###xml 1111 1120 1093 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007197-g005">Figure 5C</xref>
###xml 569 577 <span type="species:ncbi:9606">patients</span>
###xml 922 930 <span type="species:ncbi:9606">patients</span>
Because fibroblasts essentially contribute to MMP-1 production in IBD, we assessed the occurring changes of MMP-1 in primary intestinal fibroblasts upon stimulation with the ASM-activating inflammatory cytokines TNF and IL-1beta. Again, we used imipramine for pharmacologic inhibition of ASM, to analyze the contribution of ASM for production of MMP-1. Induction of MMP-1 by IL-1beta or TNF was completely abolished by imipramine in all the investigated primary fibroblasts, including three different sets from healthy control (CO I, CO II, CO III) and three sets from patients with ulcerative colitis (UC I, UC II, UC III) (Figure 5B and 5C). Upon stimulation with IL-1beta (1ng/ml) or TNF (10ng/ml), control fibroblasts increased MMP-1 secretion (Figure 5B). Treatment with imipramine abrogated the effect of IL-1beta or TNF with significant inhibition when compared to cells with IL-1beta or TNF only. Fibroblasts from patients with ulcerative colitis also increased MMP-1 while treatment with imipramine resulted in MMP-1-levels with significant inhibition when compared to cells with IL-1beta or TNF only (Figure 5C).
###end p 60
###begin p 61
It is important to note that complete serum withdrawal prestimulated the primary fibroblasts with only little response to TNF. Therefore 0.5% FCS was maintained to avoid prestimulation of primary fibroblasts by serum withdrawal.
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Wang1">[21]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Meijer1">[22]</xref>
###xml 353 361 <span type="species:ncbi:9606">patients</span>
In the present study, we analysed the levels of bioactive lipids in two models of chronic colitis and identified ceramide as a novel second messenger for disease pathology in IBD. We demonstrate that generation of ceramide and activity of acid sphingomyelinase are required for the production of MMP-1, which is believed to damage the colonic mucosa in patients with ulcerative colitis [21], [22].
###end p 63
###begin p 64
###xml 141 147 <span type="species:ncbi:10090">murine</span>
###xml 582 590 <span type="species:ncbi:9606">patients</span>
Using electrospray ionization tandem mass spectrometry (ESI-MS/MS), we found increased concentrations of ceramide in ex vivo preparations of murine intestinal epithelial cells, and decrease of the degradation product of PC lysophosphatidylcholine. Increased levels of ceramide result from upregulated sphingomyelin breakdown by sphingomyelinases and/or reduced degradation of ceramide by acid ceramidase. To determine the role of the second messenger ceramide, generated by sphingomyelin breakdown, the intestinal epithelial cell line Caco-2 and primary intestinal fibroblasts from patients with ulcerative colitis or healthy controls were challenged with exogenous SMase or the inflammatory cytokines IL-1beta and TNF to induce ceramide generation. Affymetrix gene array analysis of Caco-2 IEC revealed dramatic increases of MMP-1 and MMP-10 after generation of ceramide by exogenous SMase. Dose dependent induction of MMP-1 protein expression in Caco-2 IEC upon incubation with exogenous SMase was verified by ELISA. To our knowledge, this is the first description of MMP-1 induction by ceramide in epithelial cells with possible implications for the understanding and treatment of tumor invasion and metastasis. After all, fibroblasts need an inflammatory stimulus in addition to exogenous SMase to induce MMP-1 expression. This regulation is lost in the epithelial cancer cell line Caco-2 which responds with MMP-1 production after generation of ceramide by exogenous SMase alone.
###end p 64
###begin p 65
###xml 146 150 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Bauer1">[48]</xref>
###xml 412 416 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Albouz1">[45]</xref>
###xml 417 421 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Jensen1">[47]</xref>
###xml 577 581 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Schtze2">[49]</xref>
###xml 583 587 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Hofmeister1">[50]</xref>
###xml 1050 1056 <span type="species:ncbi:10090">murine</span>
Using acid sphingomyelinase (ASM)-deficient fibroblasts as a genetic model, we have previously shown ASM-dependent induction of MMP-1 by IL-1beta [48]. To elucidate the role of sphingomyelin degradation by ASM for MMP-1-induction in IEC and intestinal fibroblasts, activation of ASM was pharmacologically inhibited by imipramine. Imipramine interferes with ceramide signalling, particularly by inhibition of ASM [45]-[47]. TNF and IL-1beta, which are known to induce MMP-1 expression as well as to activate ASM, served to evaluate the relevance of ASM-mediated MMP-1-induction [49], [50]. Importantly, inhibition of ASM by imipramine completely abrogated the induction of MMP-1 after stimulation with TNF or IL-1beta. These data suggest that generation of ceramide by ASM upon TNF or IL-1beta augments intestinal tissue destruction by increase of MMP-1 production which can be prevented by inhibition of ASM. Unfortunately, rodents do not express MMP-1. Therefore, we were not able to explore the effects of ASM-inhibition on MMP-1 expression in our murine models of colitis.
###end p 65
###begin p 66
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Teichgrber1">[51]</xref>
###xml 375 378 375 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Sakata1">[8]</xref>
###xml 474 478 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Bock1">[52]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Lang1">[53]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Bock2">[54]</xref>
###xml 787 791 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Esmaeili1">[55]</xref>
###xml 338 344 <span type="species:ncbi:10090">murine</span>
Another consequence of ceramide accumulation may be an increase of cell death and susceptibility to infection, which was demonstrated in a very recent publication by Teichgraber et al, employing an animal model of cystic fibrosis [51]. As shown by Sakata et al., ASM also contributes to increased secretion of inflammatory cytokines in a murine model of experimental colitis [8]. Alteration of membrane fluidity by ceramide has also been shown to affect permeability of IEC [52] and the function of diverse ion channels [53], [54], which may also contribute to extensive loss of fluids and increase of IEC apoptosis in IBD. All of the effects mentioned above may be prevented by inhibition of ASM. Positive effects of imipramine on the clinical course of UC were shown by Esmaeili et al [55]. In view of our results, part of these effects are possibly explained by reduced production of MMP-1.
###end p 66
###begin p 67
###xml 109 112 109 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Fabia1">[5]</xref>
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Stremmel1">[7]</xref>
###xml 485 489 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-LiuWu1">[56]</xref>
###xml 536 540 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007197-Olofsson1">[19]</xref>
To address the question of PC administration, which has been reported to be protective in ulcerative colitis [5]-[7], we also compared levels of PC and its degradation product LPC. We did not find direct evidence for a deficiency of PC in intestinal epithelial cells but concentrations of LPC were much lower in inflamed colonic epithelium. This decrease is suggestive of a regulatory response of the mucosa to reduce inflammation, by reduction of inflammatory cytokines like IL-1beta [56] and less recruitment of monocytes and T cells [19]. Therefore, the decrease of LPC most likely represents a mechanism of the intestinal mucosa for resolution of inflammation.
###end p 67
###begin p 68
In summary, our data demonstrate increased levels of ceramide in experimental colitis. The results indicate a role of ceramide for the pathogenesis of IBD by regulation of MMP-1 expression. Pharmacologic inhibition of ASM by imipramine completely abrogates the induction of MMP-1 upon TNF or IL-1beta. Therefore, inhibition of ASM may be a possible treatment strategy for intestinal inflammation, in particular ulcerative colitis.
###end p 68
###begin title 69
References
###end title 69
###begin article-title 70
The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction.
###end article-title 70
###begin article-title 71
Tumor necrosis factor receptor-mediated signalling pathways.
###end article-title 71
###begin article-title 72
Principles of bioactive lipid signalling: lessons from sphingolipids.
###end article-title 72
###begin article-title 73
Lipid signalling in disease.
###end article-title 73
###begin article-title 74
###xml 94 97 <span type="species:ncbi:10116">rat</span>
Effects of phosphatidylcholine and phosphatidylinositol on acetic-acid-induced colitis in the rat.
###end article-title 74
###begin article-title 75
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis.
###end article-title 75
###begin article-title 76
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis.
###end article-title 76
###begin article-title 77
###xml 208 212 <span type="species:ncbi:10090">mice</span>
Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.
###end article-title 77
###begin article-title 78
The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.
###end article-title 78
###begin article-title 79
Regulation of death receptor signalling and apoptosis by ceramide.
###end article-title 79
###begin article-title 80
Ceramide signalling and the immune response.
###end article-title 80
###begin article-title 81
The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation.
###end article-title 81
###begin article-title 82
Raft ceramide in molecular medicine.
###end article-title 82
###begin article-title 83
Alkaline sphingomyelinase: an old enzyme with novel implications.
###end article-title 83
###begin article-title 84
###xml 218 222 <span type="species:ncbi:10090">mice</span>
Inhibition of lipopolysaccharide-induced release of interleukin-8 from intestinal epithelial cells by SMA, a novel inhibitor of sphingomyelinase and its therapeutic effect on dextran sulphate sodium-induced colitis in mice.
###end article-title 84
###begin article-title 85
Increased basolateral sorting of carcinoembryonic antigen in a polarized colon carcinoma cell line after cholesterol depletion-Implications for treatment of inflammatory bowel disease.
###end article-title 85
###begin article-title 86
Anti-inflammatory effects of phosphatidylcholine.
###end article-title 86
###begin article-title 87
###xml 40 45 <span type="species:ncbi:9606">human</span>
Formation of lysophosphatidylcholine by human platelets in response to thrombin. Support for the phospholipase A2 pathway for the liberation of arachidonic acid.
###end article-title 87
###begin article-title 88
Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages.
###end article-title 88
###begin article-title 89
Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase.
###end article-title 89
###begin article-title 90
Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.
###end article-title 90
###begin article-title 91
Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.
###end article-title 91
###begin article-title 92
Regulation of matrix metalloproteinase expression in tumor invasion.
###end article-title 92
###begin article-title 93
The role of matrix metalloproteinases in stromal/epithelial interactions in the gut.
###end article-title 93
###begin article-title 94
Role of matrix metalloproteinases in inflammatory bowel diseases.
###end article-title 94
###begin article-title 95
Matrix metalloproteinase inhibitors.
###end article-title 95
###begin article-title 96
Matrix metalloproteinase level are elevated in inflammatory bowel disease.
###end article-title 96
###begin article-title 97
###xml 63 71 <span type="species:ncbi:9606">children</span>
Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesion of children with inflammatory bowel disease.
###end article-title 97
###begin article-title 98
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
###end article-title 98
###begin article-title 99
###xml 119 122 <span type="species:ncbi:9823">pig</span>
Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis.
###end article-title 99
###begin article-title 100
UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6.
###end article-title 100
###begin article-title 101
Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways.
###end article-title 101
###begin article-title 102
###xml 104 109 <span type="species:ncbi:9606">human</span>
Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts.
###end article-title 102
###begin article-title 103
###xml 27 32 <span type="species:ncbi:9606">human</span>
Regulation of migration of human colonic myofibroblasts.
###end article-title 103
###begin article-title 104
Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF).
###end article-title 104
###begin article-title 105
###xml 172 176 <span type="species:ncbi:10090">mice</span>
Interferon-gamma (IFN-gamma) - and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.
###end article-title 105
###begin article-title 106
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.
###end article-title 106
###begin article-title 107
###xml 39 43 <span type="species:ncbi:10090">mice</span>
A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+ CD4+ T cells: insights into the regulatory role of interleukin-6 on apoptosis.
###end article-title 107
###begin article-title 108
###xml 13 19 <span type="species:ncbi:10090">murine</span>
###xml 31 49 <span type="species:ncbi:1358">Lactococcus lactis</span>
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.
###end article-title 108
###begin article-title 109
Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes.
###end article-title 109
###begin article-title 110
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.
###end article-title 110
###begin article-title 111
High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim Biophys Acta 1686: 108-117.
###end article-title 111
###begin article-title 112
Lipid profiling of FPLC-separated lipoprotein fraction by electrospray ionization tandem mass spectrometry.
###end article-title 112
###begin article-title 113
###xml 32 38 <span type="species:ncbi:10090">murine</span>
Epithelial heterogeneity in the murine thymus: A cell surface glycoprotein expressed by subcapsular and medullary epithelium.
###end article-title 113
###begin article-title 114
Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures.
###end article-title 114
###begin article-title 115
###xml 105 110 <span type="species:ncbi:9606">human</span>
The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts.
###end article-title 115
###begin article-title 116
Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier.
###end article-title 116
###begin article-title 117
Matrix metalloproteinase-1 expression induced by IL-1beta requires acid sphingomyelinase.
###end article-title 117
###begin article-title 118
TNF achtivates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown.
###end article-title 118
###begin article-title 119
Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein.
###end article-title 119
###begin article-title 120
Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
###end article-title 120
###begin article-title 121
Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function.
###end article-title 121
###begin article-title 122
Plasma membrane ion channels in suicidal cell death.
###end article-title 122
###begin article-title 123
Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms.
###end article-title 123
###begin article-title 124
New insights of anti-depressant therapy in the management of ulcerative colitis (UC).
###end article-title 124
###begin article-title 125
###xml 62 67 <span type="species:ncbi:9606">human</span>
Lysophosphatidylcholine induces the production of IL-1beta by human monocytes.
###end article-title 125
###begin p 126
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 126
###begin p 127
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the German Research Foundation DFG BO 2529/2-1 to JB and OB 135/10-1 to FO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 127

